WallStSmart

HealthEquity Inc (HQY)vsPhreesia Inc (PHR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

HealthEquity Inc generates 184% more annual revenue ($1.31B vs $463.20M). HQY leads profitability with a 16.4% profit margin vs -116.0%. HQY earns a higher WallStSmart Score of 68/100 (B-).

HQY

Strong Buy

68

out of 100

Grade: B-

Growth: 8.0Profit: 7.0Value: 10.0Quality: 6.5
Piotroski: 4/9

PHR

Hold

41

out of 100

Grade: D

Growth: 8.0Profit: 2.0Value: 5.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HQYUndervalued (+33.2%)

Margin of Safety

+33.2%

Fair Value

$115.13

Current Price

$82.47

$32.66 discount

UndervaluedFair: $115.13Overvalued

Intrinsic value data unavailable for PHR.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HQY3 strengths · Avg: 8.7/10
EPS GrowthGrowth
92.4%10/10

Earnings expanding 92.4% YoY

PEG RatioValuation
0.898/10

Growing faster than its price suggests

Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

PHR2 strengths · Avg: 9.0/10
Revenue GrowthGrowth
45.7%10/10

Revenue surging 45.7% year-over-year

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Areas to Watch

HQY1 concerns · Avg: 4.0/10
P/E RatioValuation
33.4x4/10

Premium valuation, high expectations priced in

PHR4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$680.04M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-1.9%2/10

ROE of -1.9% — below average capital efficiency

Profit MarginProfitability
-116.0%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : HQY

The strongest argument for HQY centers on EPS Growth, PEG Ratio, Operating Margin. Profitability is solid with margins at 16.4% and operating margin at 21.6%. PEG of 0.89 suggests the stock is reasonably priced for its growth.

Bull Case : PHR

The strongest argument for PHR centers on Revenue Growth, Price/Book. Revenue growth of 45.7% demonstrates continued momentum.

Bear Case : HQY

The primary concerns for HQY are P/E Ratio.

Bear Case : PHR

The primary concerns for PHR are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

HQY profiles as a mature stock while PHR is a hypergrowth play — different risk/reward profiles.

PHR carries more volatility with a beta of 0.72 — expect wider price swings.

PHR is growing revenue faster at 45.7% — sustainability is the question.

HQY generates stronger free cash flow (102M), providing more financial flexibility.

Bottom Line

HQY scores higher overall (68/100 vs 41/100), backed by strong 16.4% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

HealthEquity Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

HealthEquity, Inc. provides technology-enabled service platforms to consumers and employers in the United States. The company is headquartered in Draper, Utah.

Phreesia Inc

HEALTHCARE · HEALTH INFORMATION SERVICES · USA

Phreesia, Inc. provides integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company is headquartered in Raleigh, North Carolina.

Want to dig deeper into these stocks?